Critically Ill Patient with Multidrug-Resistant Acinetobacter baumannii Respiratory Infection Successfully Treated with Intravenous and Nebulized Bacteriophage Therapy

Area of Science:

• Infectious Diseases
• Microbiology
• Critical Care Medicine

Background:

• Hospitalized patients, particularly those on mechanical ventilation or with compromised immunity or chronic conditions, are susceptible to severe multidrug-resistant bacterial infections.
• Multidrug-resistant Acinetobacter baumannii (MDR-A) poses a significant threat in healthcare settings, leading to difficult-to-treat respiratory infections.

Observation:

• A 52-year-old critically ill patient presented with a severe respiratory infection caused by MDR-A.
• The patient had risk factors including mechanical ventilation and comorbidities, complicating treatment options.

Findings:

• The patient received a combination of standard antibiotic treatment and bacteriophage therapy.
• Intravenous and nebulized bacteriophage administration was employed as part of the therapeutic regimen.
• Successful eradication of the MDR-A infection was achieved with this combined approach.

Implications:

• This case highlights the potential efficacy of bacteriophage therapy as a complementary treatment for multidrug-resistant bacterial infections in critically ill patients.
• Bacteriophage therapy offers a promising alternative or adjunct to antibiotics, especially for infections caused by resistant pathogens.
• Further research into bacteriophage therapy for multidrug-resistant infections is warranted to establish its broader clinical utility.